Reviews of The Revivogen MD

Hair loss discussion includes treatments like hinoki tree oil and procyanidin b2. Experiences and effectiveness of these treatments are shared.

The conversation discusses the effectiveness of finasteride and microneedling for treating hair loss. The linked article is seen as an advertisement for these treatments.

The conversation discusses a natural alternative to Minoxidil for hair loss, with users suggesting peppermint oil and rosemary oil as potential weaker substitutes.

The conversation discusses hair loss treatments, specifically Minoxidil, finasteride, and RU58841. It also mentions observations about the Amla page on Examine.

The conversation is about hair loss treatments. Mentioned treatments include Minoxidil, finasteride, RU58841, and avodart.

The user is experiencing hair thinning on the sides and back of the head while the top remains thick. A reply suggests it might be retrograde alopecia.

The conversation is about hair loss treatments, specifically discussing the effectiveness of Red Ginseng Extract in promoting hair growth. Other treatments mentioned include Minoxidil, finasteride, and RU58841.

The conversation discusses hair loss treatments beyond the commonly known three, focusing on separating effective treatments from myths. Dutasteride and low-dose oral Minoxidil are mentioned as having clinical evidence for increasing hair counts, but with potential side effects.

The user is regrowing hair while using steroids by following a regimen that includes Rogaine, RU58841, Dutasteride, Nizoral, PGE2, and occasionally castor oil. Despite using harsh steroids like Tren, Masteron, and Proviron, the user reports successful hair regrowth.

The user shared a 9-month hair loss treatment routine that includes using Minoxidil, Finasteride, Argan Oil conditioner, Regenpure DR shampoo, fish oil, and a multi-vitamin, while also avoiding sun exposure and maintaining a healthy lifestyle. They reported successful results and provided a link to their progress pictures.

The conversation discusses the high cost of CB-03-01, a topical antiandrogen for hair loss, which is considered safe and remains localized upon application. It questions whether the expense is justified compared to the lower risks it poses relative to finasteride.

The conversation discusses hair loss treatments, specifically mentioning Minoxidil, finasteride, and RU58841. It also references upcoming trial data from Shiseido in Japan.

The conversation discusses using minoxidil for hair growth and asks for recommendations on shampoos, conditioners, and other products to support hair growth and stop hair loss. It also inquires about the frequency of washing hair and the effects of using oils like coconut oil on pores.

The user plans to combat hair loss with Finasteride 1mg daily, Minoxidil 5% twice daily, and Nizoral twice weekly. They also consider supplements like biotin, zinc, saw palmetto, and pumpkin seeds, along with a healthy diet and dermarolling.

Eating 1g of broccoli seeds five days a week may help with hair regrowth due to their high sulforaphane content. However, caution is advised due to potential health risks from erucic acid in the seeds.

The conversation discusses using topical cetirizine as a treatment for androgenetic alopecia (hair loss). Specific treatments mentioned include Minoxidil, finasteride, and RU58841.

The conversation is about the effectiveness of oils like castor, coconut, tea tree, and emu for hair loss. Users discuss their experiences and compare these oils to treatments like Minoxidil, finasteride, and RU58841.

The post discusses microdosing finasteride to minimize side effects while treating hair loss. The user also mentions using minoxidil, biotin, and ketoconazole.

The conversation discusses whether adding pumpkin seed oil to a regimen that already includes finasteride would provide any additional benefits for hair loss. The consensus is that while finasteride is effective, adding pumpkin seed oil might offer some extra benefits, but evidence is limited.

The conversation discusses a clinical trial for Setipiprant in the US, starting June 29th, with eligibility excluding recent users of minoxidil or finasteride. It encourages informed decision-making before signing up.